Trade Summary

3 days ago, Fairmount Funds Management LLC, serving as Dir, 10% owner at Viridian Therapeutics, Inc.De (VRDN), purchased 1,176,470 shares at $17.00 per share, for a total transaction value of $19,999,990.00. Following this transaction, Fairmount Funds Management LLC now holds 5,090,928 shares of VRDN.

This purchase represents a 30.00% increase in Fairmount Funds Management LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 11, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 13, 2026, 2 days after the trade was made.

Viridian Therapeutics, Inc.De operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.